These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 26662569)
1. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer. Li J; Ye Y; Wang M; Lu L; Han C; Zhou Y; Zhang J; Yu Z; Zhang X; Zhao C; Wen J; Kan Q Tumour Biol; 2016 May; 37(5):6881-91. PubMed ID: 26662569 [TBL] [Abstract][Full Text] [Related]
2. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer. Ye Y; Jiang D; Li J; Wang M; Han C; Zhang X; Zhao C; Wen J; Kan Q Tumour Biol; 2016 Mar; 37(3):3185-95. PubMed ID: 26432329 [TBL] [Abstract][Full Text] [Related]
3. Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer. Ye YW; Hu S; Shi YQ; Zhang XF; Zhou Y; Zhao CL; Wang GJ; Wen JG; Zong H Oncol Rep; 2013 Dec; 30(6):2777-84. PubMed ID: 24126887 [TBL] [Abstract][Full Text] [Related]
4. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA]. Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression. Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388 [TBL] [Abstract][Full Text] [Related]
6. Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells. Jiang D; Li J; Li J; Wang M; Han C; Wang X; Zhao C; Ye Y Int J Oncol; 2017 Nov; 51(5):1611-1620. PubMed ID: 29048661 [TBL] [Abstract][Full Text] [Related]
7. [Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803]. Wu Q; Yu JC; Liu YQ; Kang WM; Guo WD Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):65-70. PubMed ID: 20236591 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949 [TBL] [Abstract][Full Text] [Related]
9. [Effects of traditional Tibetan drug Liu Tea on proliferation and chemotherapeutic sensitivity of drug-resistant human gastric cancer cell BGC823/5-FU]. Cheng Y; Hasiqi MG; Qin XZ; Tang XY; Chen JN; Wang HY; Gao A Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):603-608. PubMed ID: 28871679 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer. Turkington RC; Longley DB; Allen WL; Stevenson L; McLaughlin K; Dunne PD; Blayney JK; Salto-Tellez M; Van Schaeybroeck S; Johnston PG Cell Death Dis; 2014 Feb; 5(2):e1046. PubMed ID: 24503538 [TBL] [Abstract][Full Text] [Related]
11. Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells. Liu Y; Bi T; Dai W; Wang G; Qian L; Shen G; Gao Q Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):477-84. PubMed ID: 26892272 [TBL] [Abstract][Full Text] [Related]
12. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice. Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621 [TBL] [Abstract][Full Text] [Related]
14. BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro. Zhang X; Zhang X; Han R; Wang Z; Yang Q; Huang Y; Yan Y Biochem Biophys Res Commun; 2022 Mar; 595():22-27. PubMed ID: 35093636 [TBL] [Abstract][Full Text] [Related]
15. Jianpi Yangwei decoction promotes apoptosis and suppresses proliferation of 5-fluorouracil resistant gastric cancer cells in vitro and in vivo. Tang H; Huang W; Yang Q; Lin Y; Chen Y; Shu P BMC Complement Med Ther; 2020 Nov; 20(1):337. PubMed ID: 33167958 [TBL] [Abstract][Full Text] [Related]
16. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition. Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983 [TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Ezzat S; Huang P; Dackiw A; Asa SL Clin Cancer Res; 2005 Feb; 11(3):1336-41. PubMed ID: 15709206 [TBL] [Abstract][Full Text] [Related]
18. Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil. Wang J; Hu W; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J Int J Oncol; 2016 Apr; 48(4):1341-52. PubMed ID: 26847910 [TBL] [Abstract][Full Text] [Related]
19. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth. Kim HM; Kim SA; Park SB; Cho JH; Song SY Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575 [TBL] [Abstract][Full Text] [Related]
20. Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil. Chen WY; Huang CY; Cheng WL; Hung CS; Huang MT; Tai CJ; Liu YN; Chen CL; Chang YJ Tumour Biol; 2015 Dec; 36(12):9537-44. PubMed ID: 26136123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]